数字乳腺断层摄影与单独数字乳腺X线摄影检出乳腺癌的对比增强MRI疾病范围评估
回顾性比较数字乳腺断层摄影(DBT)与数字乳腺X线摄影(DM)筛查检出乳腺癌后MRI评估疾病范围的效用:DBT队列82例中MRI真阳性7例(8.5%),DM队列23例中真阳性7例(30%),DBT队列真阳性率显著更低(p=0.013),假阳性率相似,差异主要见于非致密乳腺女性(p=0.001)。
要点
- DBT筛查检出乳腺癌后术前MRI真阳性率8.5%(7/82),低于DM的30%(7/23),差异显著(p=0.013)。
- 两队列假阳性率相似,无统计学显著差异。
- 真阳性率差异主要在非致密乳腺女性中观察到(p=0.001)。
核心结论
- 在DM和DBT筛查检出的新诊断乳腺癌人群中,MRI均能检出额外癌灶,但DBT筛查检出癌患者术前MRI的正面影响减弱,尤其在非致密乳腺女性中。
研究设计与样本
- 回顾性研究,回顾24563例DBT筛查患者和10751例DM筛查患者;DBT组235例随后行MRI,其中82例用于新诊断乳腺癌疾病范围评估;DM组83例随后行MRI,其中23例用于疾病范围评估;以对侧乳腺或距原发灶>2 cm发现额外病变为MRI真阳性;采用卡方检验和Bonferroni校正事后检验比较癌亚型和MRI结果差异。
诊断标准与关键数值
- MRI疾病范围评估真阳性定义为对侧乳腺或距原发恶性病灶>2 cm处发现额外病变;DBT队列真阳性7/82(8.5%),DM队列真阳性7/23(30%),DBT显著更低(p=0.013);假阳性率两组相似(无统计学显著差异);按乳腺密度分层,差异主要在非致密乳腺女性中观察到(p=0.001)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To compare the utility of breast magnetic resonance imaging (MRI) in determining the extent of disease in patients with newly diagnosed breast cancer detected on combination digital breast tomosynthesis (DBT) versus digital screening mammography (DM).
MATERIALS AND METHODS: Review of 24,563 DBT-screened patients and 10,751 DM-screened patients was performed. Two hundred and thirty-five DBT patients underwent subsequent MRI examinations; 82 to determine extent of disease after newly diagnosed breast cancer. Eighty-three DM patients underwent subsequent MRI examinations; 23 to determine extent of disease. MRI examinations performed to assess disease extent were considered true positives if additional disease was discovered in the contralateral breast or >2 cm away from the index malignancy. Differences in cancer subtypes and MRI outcomes between the DM and DBT cohorts were compared using chi-squared tests and post-hoc Bonferroni-adjusted tests for equal proportions.
RESULTS: No differences in cancer subtype findings were observed between the two cohorts; however, MRI outcomes were found to differ between the DBT and DM cohorts (p=0.024). Specifically, the DBT cohort had significantly (p=0.013) fewer true-positive findings (7/82, 8.5%) than did the DM cohort (7/23; 30%), whereas the false-positive rate was similar between the cohorts (not statistically significant). When stratifying by breast density, this difference in true-positive rates was primarily observed when evaluating women with non-dense breasts (p=0.001).
CONCLUSION: In both the DM- and DBT-screened populations with new cancer diagnoses, MRI is able to detect additional cancer; however, in those patients who have DBT screen-detected cancers the positive impact of preoperative MRI is diminished, particularly in those women with non-dense breasts.
引用
- Chudgar AV, Conant EF, Weinstein SP, et al. Assessment of disease extent on contrast-enhanced MRI in breast cancer detected at digital breast tomosynthesis versus digital mammography alone. Clin Radiol. 2017. PMID: 28318506. doi:10.1016/j.crad.2017.02.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。